Laurie Toich, Assistant Editor

Not planning pregnancy in women with epilepsy could lead to fetal malformations.

For the first time, the new International League Against Epilepsy (ILAE) seizure classifications were presented at the American Epilepsy Society conference during the Annual Fundamentals Symposium: The New Definition and Classification of Epilepsy on Friday, December 2, 2016.

The definition of epilepsy has been updated by the International League Against Epilepsy.

Speakers discuss the state of epilepsy care around the world at the AES conference.

The finalized rule will improve payment for care relating to chronic diseases, mental health, and cognitive impairment.

The report examines changing areas that will impact pharmacists.

Pharmacy teams from 6 institutes won the ASHP Best Practices Award.

Reovirus may treat primary liver cancer and hepatitis C virus.

Ninlaro regimen increased progression-free survival by 40% in patients with multiple myeloma.

Medical marijuana may fall under specialty pharmacy in the future.

Patients with addiction or mental health conditions may benefit from treatment with marijuana.

The new method makes breast imaging less risky, and can lessen false-positive readings.

The For Your Sweetheart campaign aims to improve education about the link between heart disease and diabetes.

Unsealed court testimony emphasizes the problems with the merger among healthcare giants.

Trametinib targets a type of immune cell that inhibits T cell response in cancer.

Memantine increases the risk of developing pneumonia by 1.6 times.

The new tool will allow physicians to share data easier and supports quality patient care.

Recall issued for 30 lots of sterile products manufactured by Cantrell Drug Company.

The cost of providing essential medications may not be too costly in low- and middle-income countries.

Top news of the day from across the healthcare landscape.

Etanercept found equally effective treating plaque psoriasis compared with Enbrel.

Variants of GAL are more common among women, which may explain the high prevalence of multiple sclerosis.

Eli Lilly will not continue development on solanezumab for patients with mild cognitive impairment from Alzheimer’s disease.

Tri-Coast Pharmacy is recalling various lots of products with sterility assurance concerns.

New findings show that treatment with cabozantinib decreased mortality risk by 20% in patients with metastatic kidney cancer.

Increased levels of tumor-associated myeloid cells reduce cancer cell sensitivity to treatments.

Top news of the day from across the healthcare landscape.

Nonadherence costs $564 billion in losses for pharmaceutical manufacturers worldwide.

Soliqua 100/33 is a combination treatment of Lantus and lixisenatide for the treatment of type 2 diabetes.

The tool makes screening novel drugs for potential toxicities much easier.